Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtide

Maria Buti; Heiner Wedemeyer; Soo Aleman; Vladimir Chulanov; Viacheslav Morozov; Olga Sagalova; Tatiana Stepanova; Robert G. Gish; Andrew Lloyd; Ankita M. Kaushik; Vithika Suri; Dmitry Manuilov; Anu O. Osinusi; John F. Flaherty; Pietro Lampertico

doi:10.1016/j.jhep.2024.06.031

Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtide

Maria Buti
, Heiner Wedemeyer
, Soo Aleman
, Vladimir Chulanov
, Viacheslav Morozov
, Olga Sagalova
, Tatiana Stepanova
, Robert G. Gish
, Andrew Lloyd
, Ankita M. Kaushik
, Vithika Suri
, Dmitry Manuilov
, Anu O. Osinusi
, John F. Flaherty
, Pietro Lampertico

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	28-36
Number of pages	9
Journal	Journal of Hepatology
Volume	82
Issue number	1
DOIs	https://doi.org/10.1016/j.jhep.2024.06.031
State	Published - Jan 2025
Externally published	Yes

ASJC Scopus Subject Areas

Hepatology

Keywords

Bulevirtide
EQ-5D-3L
Fatigue Severity Scale (FSS)
Hepatitis Quality of Life Questionnaire (HQLQ)
chronic hepatitis delta (CHD)
health-related quality of life (HRQoL)
hepatitis delta virus (HDV)

Access to Document

10.1016/j.jhep.2024.06.031

OpenUrl availability

Full text

Cite this

Buti, M., Wedemeyer, H., Aleman, S., Chulanov, V., Morozov, V., Sagalova, O., Stepanova, T., Gish, R. G., Lloyd, A., Kaushik, A. M., Suri, V., Manuilov, D., Osinusi, A. O., Flaherty, J. F., & Lampertico, P. (2025). Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtide. Journal of Hepatology, 82(1), 28-36. https://doi.org/10.1016/j.jhep.2024.06.031

Buti, M, Wedemeyer, H, Aleman, S, Chulanov, V, Morozov, V, Sagalova, O, Stepanova, T, Gish, RG, Lloyd, A, Kaushik, AM, Suri, V, Manuilov, D, Osinusi, AO, Flaherty, JF & Lampertico, P 2025, 'Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtide', Journal of Hepatology, vol. 82, no. 1, pp. 28-36. https://doi.org/10.1016/j.jhep.2024.06.031

@article{0107bc502c6f42e79977c10737f8665e,

title = "Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtide",

keywords = "Bulevirtide, EQ-5D-3L, Fatigue Severity Scale (FSS), Hepatitis Quality of Life Questionnaire (HQLQ), chronic hepatitis delta (CHD), health-related quality of life (HRQoL), hepatitis delta virus (HDV)",

author = "Maria Buti and Heiner Wedemeyer and Soo Aleman and Vladimir Chulanov and Viacheslav Morozov and Olga Sagalova and Tatiana Stepanova and Gish, \{Robert G.\} and Andrew Lloyd and Kaushik, \{Ankita M.\} and Vithika Suri and Dmitry Manuilov and Osinusi, \{Anu O.\} and Flaherty, \{John F.\} and Pietro Lampertico",

note = "Publisher Copyright: {\textcopyright} 2024 The Authors",

year = "2025",

month = jan,

doi = "10.1016/j.jhep.2024.06.031",

language = "English",

volume = "82",

pages = "28--36",

journal = "Journal of Hepatology",

issn = "0168-8278",

number = "1",

}

TY - JOUR

T1 - Patient-reported outcomes in chronic hepatitis delta

T2 - An exploratory analysis of the phase III MYR301 trial of bulevirtide

AU - Buti, Maria

AU - Wedemeyer, Heiner

AU - Aleman, Soo

AU - Chulanov, Vladimir

AU - Morozov, Viacheslav

AU - Sagalova, Olga

AU - Stepanova, Tatiana

AU - Gish, Robert G.

AU - Lloyd, Andrew

AU - Kaushik, Ankita M.

AU - Suri, Vithika

AU - Manuilov, Dmitry

AU - Osinusi, Anu O.

AU - Flaherty, John F.

AU - Lampertico, Pietro

PY - 2025/1

Y1 - 2025/1

KW - Bulevirtide

KW - EQ-5D-3L

KW - Fatigue Severity Scale (FSS)

KW - Hepatitis Quality of Life Questionnaire (HQLQ)

KW - chronic hepatitis delta (CHD)

KW - health-related quality of life (HRQoL)

KW - hepatitis delta virus (HDV)

UR - https://www.scopus.com/pages/publications/85209252172

UR - https://www.scopus.com/pages/publications/85209252172#tab=citedBy

U2 - 10.1016/j.jhep.2024.06.031

DO - 10.1016/j.jhep.2024.06.031

M3 - Article

C2 - 39009085

AN - SCOPUS:85209252172

SN - 0168-8278

VL - 82

SP - 28

EP - 36

JO - Journal of Hepatology

JF - Journal of Hepatology

IS - 1

ER -

Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtide

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this